Pulmonx Corp (LUNG)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 23,859 | 22,538 | 20,387 | 20,783 |
| Cost of goods sold | 6,655 | 6,196 | 5,361 | 5,476 |
| Gross profit | 17,204 | 16,342 | 15,026 | 15,307 |
| Selling, general and administrative | 26,702 | 26,149 | 25,411 | 25,314 |
| Research and development | 5,306 | 4,756 | 3,744 | 5,615 |
| Total operating expenses | 32,008 | 30,905 | 29,155 | 30,929 |
| Loss from operations | -14,804 | -14,563 | -14,129 | -15,622 |
| Interest income | 723 | 864 | 1,269 | 1,306 |
| Interest expense | 799 | 781 | 891 | 891 |
| Other (expense) income, net | -116 | 167 | -201 | -35 |
| Net loss before tax | -14,996 | -14,313 | -13,952 | -15,242 |
| Income tax expense | 177 | 135 | 192 | 84 |
| Net loss | -15,173 | -14,448 | -14,144 | -15,326 |
| Currency translation adjustment | 435 | 111 | 412 | 40 |
| Change in unrealized losses on marketable securities | -1 | -22 | 149 | -30 |
| Total other comprehensive income (loss) | 434 | 89 | 561 | 10 |
| Comprehensive loss | -14,739 | -14,359 | -13,583 | -15,316 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.38 | -0.36 | -0.36 | -0.39 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.38 | -0.36 | -0.36 | -0.39 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 40,429,655 | 39,954,658 | 39,276,447 | 38,943,066 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 40,429,655 | 39,954,658 | 39,276,447 | 38,943,066 |